Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Induced Pluripotent Stem Cell
100%
Diabetes
100%
Maturity Onset Diabetes of the Young
100%
Transgene
100%
Diseases
100%
Somatic Cell
66%
Patient with Type 1 Diabetes
33%
Infection
33%
Oxidative Stress
33%
Gene Expression
33%
Pancreatic Islet
33%
Diabetes Mellitus
33%
Patient with Diabetes
33%
Lentivirus Vector
33%
down Regulation
33%
Virus Genome
33%
Virus Vector
33%
Gene Expression Profiling
33%
Retrovirus Vector
33%
Pluripotent Stem Cell
33%
Cell Replacement Therapy
33%
Biochemistry, Genetics and Molecular Biology
Transgene
100%
Induced Pluripotent Stem Cell
100%
Reprogramming
100%
Somatic Cell
100%
Disease Modeling
50%
Gene Expression Profiling
50%
Stem Cell
50%
Gene Expression
50%
Oxidative Stress
50%
Lentivirus Vector
50%
down Regulation
50%
Retrovirus Vector
50%
Virus Genome
50%
Virus Vector
50%
Genomics
50%
Keyphrases
Type 2 Diabetes Mellitus (T2DM)
100%
Induced Pluripotent Stem Cells (iPSCs)
100%
Transgene-free
100%
Sendai
30%
Diabetes
20%
Patient-specific
20%
Somatic Cells
20%
Type I Diabetes
10%
Type 1 Diabetes Mellitus (T1DM)
10%
Lentiviral Vector
10%
Therapeutic Approaches
10%
Islet
10%
Pancreatic Islets
10%
Genetic Modification
10%
Biosafety
10%
Diabetes Complications
10%
Pluripotent Stem Cells
10%
P16INK4a
10%
Patients with Diabetes
10%
Pluripotent
10%
Oxidative Stress Response
10%
Pluripotency
10%
Personalized Therapy
10%
Disease Modeling
10%
Diabetic Patients
10%
Embryonic Cells
10%
P21Cip1
10%
Older Individuals
10%
Viral Genome
10%
Diagnostic Approach
10%
Viral Antigens
10%
Cell Source
10%
Vector Integration
10%
Cell Replacement Therapy
10%
Global Gene Expression Profiling
10%
Vector System
10%
P15INK4b
10%
Non-integrating
10%
Patient Cells
10%
85-year-old
10%
Host Genome
10%
INK4
10%
Vector Infection
10%
Autologous Cells
10%
Pluripotency Genes
10%
Redifferentiation
10%
Integration-free Reprogramming
10%
Modifier-free
10%
Sendai Virus Vector
10%
Personalized Diagnostics
10%
Differentiation Propensity
10%
Comparative Transcriptome Analysis
10%
Retroviral Vector
10%
Induced Pluripotent Stem Cell Technology
10%